- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01570972
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
There is growing evidence that the majority of the psychosocial deterioration that accompanies psychotic disorders occurs during the first few years of illness and that the prevention or delay of early deterioration may be associated with a better course of illness. Two interventions which have been shown to improve the course of recent-onset psychosis are multifamily group psychoeducation [MFG] and group cognitive behavioral therapy [GCBT]. Both family psychoeducation and cognitive behavioral therapy have been recommended as components of usual care for psychotic disorders by the Schizophrenia Patient Oriented Research Team convened by the U.S. Department of Health and Human Services (10) as well as other international health organizations. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.
Purpose and Objectives
The goal of this study is to clarify the mechanisms through which MFG and GCBT produce their clinical benefits (i.e., mediators) and identify the factors that may maximize an individual's response to these two empirically-validated interventions (i.e., moderators).
Methods
All participants will be provided with 2 years of of GCBT and MFG and will complete regular assessments with regard to clinical and functional outcomes as well as potential mediators and moderators of these outcomes.
Significance of the Study
Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could lead to improvements in the treatment of first-episode psychosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- University of Arizona Department of Psychiatry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (Individual with Recent-Onset Psychosis):
- Diagnosis of a non-substance induced psychotic disorder (schizophrenia spectrum or affective spectrum) per the Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revised (DSM-IV-TR) criteria determined using the Structured Clinical Interview for the DSM-IV.
- Age between 18-35
- Willing to participate in interventions at University of Arizona Medical Center South Campus
- Willing to complete research assessments
- Duration of psychotic symptoms of less than 5 years determined using the Symptom Onset in Schizophrenia inventory
- Able to provide informed consent
- Fluent in English
- Willing to allow videotaping of group cognitive behavioral therapy sessions, multifamily group sessions, and family interaction task.
Exclusion Criterion (Individual with Recent Onset Psychosis)
- No evidence of mental retardation as defined as never having qualified to receive services from the Arizona Department of Economic Security, Division of Developmental Disabilities.
Inclusion Criteria (Family Caregiver):
- Must be someone that the individual with recent-onset psychosis identifies as providing support and care to the individual with recent-onset psychosis. Does not need to be a biological relative.
- Must spend considerable time with the individual with recent-onset psychosis as defined at 10 hours or more of direct contact per week.
- Willing to participate in participate in family intervention at University of Arizona Medical Center, South Campus for 2 years
- Willing to complete research assessments
- Able to provide informed consent
- Fluent in English
- Willing to allow videotaping of multifamily group sessions, Camberwell Family Interview, and family interaction task.
Exclusion Criterion (Family Caregiver)
- Diagnosis of a psychotic disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: MFG and GCBT
There is a single arm for this study.
All participants will be able to participate in MFG and GCBT
|
weekly
twice monthly
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in General level of functioning at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
General level of functioning to be assessed using the General Assessment of Functioning (GAF) scale
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Change from baseline in self-reported Physical Health at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
Self-reported physical health assessed using the RAND-36 Health Survey
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Change from baseline in Social and vocational Functioning at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
Social and Vocational functioning to be assessed using the Social Functioning Scale
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Change from baseline in Stage of Recovery at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
Stage of recovery assessed using the Stage of Recovery Instrument
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Change from baseline Service Utilization at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
Service utilization as assessed using the Service Utilization Record Form
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Change from Baseline Quality of Life at 6 months, 12 months, 18 months, and 24 months
Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months
|
Quality of Life as assessed using the WHO Quality of Life Scale Brief
|
Baseline, 6 months, 12 months, 18 months, 24 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Breitborde NJK, Bell EK, Woolverton C, Pine JG, Waslter H, Moe AM. Cost Utility of cognition-enhancing interventions for individuals with first-episode psychosis: a naturalistic evaluation. Cost Eff Resour Alloc. 2021 Jul 1;19(1):36. doi: 10.1186/s12962-021-00292-6.
- Breitborde NJ, Bell EK, Dawley D, Woolverton C, Ceaser A, Waters AC, Dawson SC, Bismark AW, Polsinelli AJ, Bartolomeo L, Simmons J, Bernstein B, Harrison-Monroe P. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service. BMC Psychiatry. 2015 Oct 28;15:266. doi: 10.1186/s12888-015-0650-3.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- U. Az IRB 09-1113-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on Group Cognitive Behavioral Therapy
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Nova Scotia Health AuthorityTerminatedGeneralized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic DisorderCanada
-
Danette Conklin, PhDCompletedBipolar Disorder | Menopause | Major Depressive DisorderUnited States
-
Philipps University Marburg Medical CenterInstitute of Behavioral-Therapy and -Medicine at the Philipps University... and other collaboratorsCompletedDepressive Symptoms | Anxiety Symptoms | Somatoform SymptomsGermany
-
Hong Kong Baptist UniversityCompletedCognitive Behavior Group TherapyHong Kong
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH)Completed
-
Necmettin Erbakan UniversityCompletedTrauma and Stressor Related DisordersTurkey
-
Southeast University, ChinaThe Affiliated Obstetrics and Gynecology Hospital of Nanjing Medical UniversityUnknownMenopausal SyndromeChina
-
Seoul National University Boramae HospitalCompletedDepression | Quality of Life | Kidney Failure, ChronicKorea, Republic of